What is the global market size of the Vascular Grafts Market?

Global Vascular Grafts Market size was valued at USD 3.8 billion in 2021 and is poised to grow from USD 4.08 billion in 2022 to USD 7.16 billion by 2030, growing at a CAGR of 7.3% in the forecast period (2023-2030).

Who are the key vendors in the Global Vascular Grafts Market?

Global vascular grafts market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Medtronic plc', 'W. L. Gore and Associates, Inc.', 'Getinge AB', 'LeMaitre Vascular, Inc.', 'Cook Medical', 'B.Braun', 'C. R. Bard', 'Terumo Corporation', 'Endologix', 'Shanghai Suokang Medical Implants Co. Ltd.', 'Cardinal Health'

What is the key driver of the Global Vascular Grafts Market?

One of the main risk factors for diabetes, hypertension, cardiovascular diseases, and other diseases is chronic kidney disease (CKD), also known as chronic kidney failure. It involves a progressive decline in kidney function. Advanced chronic kidney disease can cause the body to accumulate hazardous amounts of fluids, electrolytes, and waste. Over 37 million adults in the U.S. have CKD, according to the National Institute of Diabetes and Digestive and Kidney Diseases. The prevalence of cardiovascular disorders is increased by hereditary factors, alcohol and tobacco use, and lifestyle choices. The WHO estimates that 17.9 million deaths worldwide in 2019 were caused by cardiovascular diseases (CVDs), or 32% of all deaths. About 85% of these were caused by heart attacks and strokes. Additionally, as more people are diagnosed with cancer, there is a greater need for implantable ports & grafts and central venous catheters to administer chemotherapy drugs and blood transfusions.

What is the key market trend for the Global Vascular Grafts Market?

The adoption of the MIDCAB procedure has increased due to the rising demand for minimally invasive procedures and its safety and low mortality rate. Additionally, it is compatible with cardiopulmonary bypass and aortic cross-clamp. Additionally, it is anticipated that in the coming years, the development of surgical procedures utilizing coronary artery stent grafts will increase demand for vascular grafts.

Which region accounted for the largest share in the Global Vascular Grafts Market?

North America accounted for a major global vascular graft market share in 2021, due to increasing health consciousness and the accessibility of cardiovascular treatment facilities within the region. Furthermore, the existence of reimbursement guidelines and the use of sophisticated technological procedures are also driving market expansion.

Vascular Grafts Market Regional Analysis

Skyquest Technology's expert advisors have carried out comprehensive global market analysis on the vascular grafts market, covering regional industry trends and market insights. Our team of analysts have conducted in-depth primary and secondary research to provide regional industry analysis and forecast of vascular grafts market across North America, South America, Europe, Asia, the Middle East, and Africa.

Vascular Grafts Market Regional Insights

North America secures the top spot when it comes to global vascular grafts demand. The presence of a developed healthcare infrastructure, high healthcare spending potential, and rising prevalence of diseases requiring vascular treatment and surgeries are helping the high vascular grafts market share of this region. The United States is slated to emerge as the most opportune market in North America owing to surge in geriatric patient population. Canada is also estimated to boost the demand for vascular grafts in this region going forward. Availability of favorable reimbursement policies and quick adoption of advanced medical technologies are also expected to bolster market growth in North America through 2031.

Asia-Pacific is expected to emerge as the fastest-expanding regional market for vascular graft companies in the world. Rising investments in healthcare infrastructure development, growing adoption of vascular surgeries, and increasing healthcare spending are slated to help bolster sales of vascular grafts in the future. Japan is slated to be a highly opportune market as senescent population reaches new heights in the country. China and India are also estimated witness a robust hike in demand for vascular grafts over the coming years. High incidence of diabetes and hypertension among people in this region will also create new opportunities for vascular graft companies in the long run.

Vascular Grafts Market Report Snapshots

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

Vascular Grafts Market size was valued at USD 1.6 Billion in 2023 and is poised to grow from USD 1.72 Billion in 2024 to USD 3 Billion by 2032, growing at a CAGR of 7.2% during the forecast period (2025-2032).

Vascular graft manufacturers should focus on making their products more affordable to enhance the accessibility to vascular procedures. Addressing the risks of complications and failures will also be crucial in determining the vascular grafts industry growth potential going forward. Vascular grafts providers should also focus on gaining new approvals for advanced vascular grafts designed for minimally invasive procedures. 'Medtronic ', 'Terumo ', 'C. R. Bard ', 'B. Braun Melsungen AG ', 'Cardinal Health ', 'Endologix ', 'LeMaitre Vascular ', 'Cook Medical ', 'Maquet ', 'Gore Medical'

Poor lifestyle choices and growing adoption of unhealthy habits have significantly increased the number of people suffering from cardiovascular diseases such as atherosclerosis, coronary artery disease, and peripheral artery disease. These indications are being treated with vascular repair procedures and surgeries thereby driving vascular grafts sales as well.

Development of Bioengineered Vascular Grafts: Bioengineered vascular grafts mimic the function of blood vessels and reduce the risk of infection and rejection that is prevalent in conventional vascular grafts. The use of bioresorbable materials and regenerative medicine approaches in vascular graft development is expected to offer a plethora of new opportunities for new as well as established vascular graft companies in the long run.

North America secures the top spot when it comes to global vascular grafts demand. The presence of a developed healthcare infrastructure, high healthcare spending potential, and rising prevalence of diseases requiring vascular treatment and surgeries are helping the high vascular grafts market share of this region. The United States is slated to emerge as the most opportune market in North America owing to surge in geriatric patient population. Canada is also estimated to boost the demand for vascular grafts in this region going forward. Availability of favorable reimbursement policies and quick adoption of advanced medical technologies are also expected to bolster market growth in North America through 2031.

Vascular Grafts Market Regional Analysis

Vascular Grafts Market Regional Insights

Vascular Grafts Market Report Snapshots

FAQs

What is the global market size of Vascular Grafts Market?

Who are the key vendors in the Vascular Grafts Market?

What is the key driver of Vascular Grafts Market?

What is the key market trend for Vascular Grafts Market?

Which region accounted for the largest share in Vascular Grafts Market?

Request Free Customization